Harnessing diversity: Examining the feasibility of conducting oncology trials in South Africa. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a ...

2. Trial visits are kept to a minimum with potential utilization of telemedicine or stipends increase attendance 3. Trial mimics typical clinical workflow with minimization of visits, and laboratory ...

Over the past several years, pharmaceutical companies have been steadily integrating artificial intelligence (AI) into many aspects of clinical development. Today, AI’s impact is being felt from the ...

Despite rapid growth, only 9.2% of DCTs are multiregional and over 80% single-country, indicating challenges in international implementation. 2 With regulatory agencies 4–7 underscoring risk-based ...